Skip to main content

Day: October 14, 2022

TUGA Welcomes Lucas Leonardi to Board of Directors

Business-building entrepreneur brings global focus on automotive software VANCOUVER, British Columbia and LISBON, Portugal, Oct. 14, 2022 (GLOBE NEWSWIRE) — TUGA Innovations, Inc. (CSE: TUGA) (FRA: DQ5) (OTC: TUGAF) (“TUGA Innovations,” or the “Company”), which is developing solutions for urban mobility challenges with the TUGA, a new type of electric vehicle (“EV”), is pleased to announce and welcome Mr. Lucas Leonardi to its board of directors with immediate effect. Mr. Leonardi is currently the Automotive Global Accounts Team Director at Amazon Web Services EMEA based in Paris, France. He brings over 25 years of sales & product marketing experience (business development, original equipment manufacturer agreements and profit and loss statement management) in software and related software as a service industry endeavour....

Continue reading

NASCAR Rivals is Available Today – The Officially Licensed Video Game of the 2022 NASCAR Season From Motorsport Games

Motorsport Games’ latest installment of the NASCAR gaming franchise combines aspects of racing rivalries into a single user experienceNASCAR RIVALS IS AVAILABLE TODAY – THE OFFICIALLY LICENSED VIDEO GAME OF THE 2022 NASCAR SEASON FROM MOTORSPORT GAMES NASCAR RIVALS IS AVAILABLE TODAY – THE OFFICIALLY LICENSED VIDEO GAME OF THE 2022 NASCAR SEASON FROM MOTORSPORT GAMESMIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and esports ecosystem provider of official motorsport racing series throughout the world, announced today the launch of NASCAR Rivals, exclusive for Nintendo Switch consoles. The officially licensed video game of the 2022 NASCAR Cup Series season, this latest installment of the video game franchise combines the...

Continue reading

HXPN, Inc. announces 2022 Q1, Q2 Revenue, Sheppard Pool Energy Oil Recompletion Flow Test Results, Bayou Villars First Well Recompletion Oil Production Rate.

FRISCO, TEXAS, Oct. 14, 2022 (GLOBE NEWSWIRE) — HXPN, Inc. (OTC PINK: HXPN) (the “Company”), an emerging technology and mineral resources development company, today announced 2022 1st Quarter revenue of $1,175,000, and 2022 2nd Quarter revenue of $640,000, with each resulting from the sale of a net profits interest in its Sheppard Pool Energy investment and its Bayou Villars investment, respectively, with each investment being announced earlier this year. The Company owns 75% of Sheppard Pool Energy. The sale of the net profits interest of the Sheppard Pool Energy recompletion project is one third (1/3rd) of the net profits of the production of the fifteen (15) wells that the Company will re-complete. The sale of the net profits interest of the Bayou Villars recompletion project is one half (1/2) of the net profits of the production...

Continue reading

BMF-219 Enters the Clinic for KRAS Solid Tumors

Biomea Fusion announces FDA clearance of Investigational New Drug (IND) application for covalent menin inhibitor BMF-219 in KRAS solid tumors. Biomea Fusion will now initiate a Phase I/Ib clinical trial (COVALENT-102) of BMF-219 as a monotherapy in patients who have unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC), colorectal cancer (CRC) or pancreatic ductal adenocarcinoma (PDAC) with a KRAS mutation. This Phase I/Ib clinical trial will expand BMF-219’s clinical development to solid tumors; Biomea Fusion is currently underway with COVALENT-101, a Phase I clinical trial studying BMF-219 in multiple blood cancers. BMF-219 is the first menin inhibitor to enter clinical trials for the treatment of solid tumors. A targeted pan-KRAS inhibitor has the potential to treat 25-35% of NSCLC, 35-45% of CRC, and approximately...

Continue reading

Plug Provides 2022 Revenue Expectations Update Reflecting Potential Timing and Supply Chain Impact

Demand and Pipeline Remains Robust LATHAM, N.Y., Oct. 14, 2022 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, provides revenue expectations update for 2022. The company believes that its prior full year 2022 revenue guidance of $900-$925M could be 5% -10% lower for the year. The revenue impact reflects some larger projects potentially being completed in 2023 instead of 2022 due to timing and broader supply chain issues. While revenue could be lower than previously anticipated in 2022, demand for the fuel cell applications and electrolyzer business remains robust. The Company recently became aware of the potential impact to its full year 2022 revenue and believes it is prudent to update stakeholders. It is important to note that the company...

Continue reading

Decision adopted in the Extraordinary General Meeting of Shareholders of AB Amber Grid

At the Extraordinary General Meeting of Shareholders of AB Amber Grid (legal entity code 303090867, office address Laisvės pr. 10, LT-04215 Vilnius, Republic of Lithuania) on 14 October 2022 decision was adopted regarding the approval of the conclusion of procurement contracts for the reconstruction of sections of the gas pipeline Vilnius – Kaunas. Contracts will be concluded when all approvals, decisions and necessary procedures required for the signing and execution of the contracts have been obtained or completed, as required by the Articles of Association of AB Amber Grid and relevant legal acts of the Republic of Lithuania. The following decision was adopted at the Extraordinary General Meeting of Shareholders AB Amber Grid: 1. Regarding approval of AB Amber Grid Board’s decision of 20 September 2022 (minutes No. VLD-19) Decision...

Continue reading

Walmart to Expand Sales of Biomerica’s Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

Simple at-home device to increase sensitivity in breast self-exams Early detection of breast cancer saves lives About 80% of breast cancer is detected by women themselves who notice changes in their breastIRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company’s Aware® Breast Self Exam device will now be sold in over 2400 Walmart’s retail stores. In July, the Company announced that Walmart had begun selling the Aware product online through Walmart.com. Walmart has now determined to also sell Aware in-store, at approximately 50% of their retail store locations. Biomerica has received and shipped an Initial stocking order from Walmart, and the product should be on store shelves within weeks. The...

Continue reading

Smart for Life Featured by New to the Street

Interviews to Air on National Television Including Bloomberg and Fox Business MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide announced that a series of interviews hosted by New to the Street featuring A.J. Cervantes, Jr., Founder and Chairman, and Darren Minton, Chief Executive Officer will begin airing on national television, including Bloomberg and Fox Business. “Having completed five material acquisitions in just the last year alone, there are significant ongoing corporate developments, and we are honored that Smart for Life will be featured in a series of interviews hosted by New to the Street that will air on national television....

Continue reading

Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA

New York, NY, and Tel Aviv, ISRAEL, Oct. 14, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified clinical laboratory Provista Diagnostics has filed an Emergency Use Authorization (EUA) application with the US Food & Drug Administration (FDA) for its PCR MonkeyPox Test. The EUA application was submitted for lesion-based PCR. The sensitivity achieved for the currently available lesion-based laboratory-developed test (LDT) is 0.95 viral copies per reaction (0.095 copies/ul). “The submission of this EUA application underscores our commitment to providing best-in-class PCR-based testing for emerging infectious diseases,” said Gerald E. Commissiong, President & CEO of Todos Medical and...

Continue reading

Turbine Oil Market is projected to reach $1.91 Billion by 2030 Globally, at a CAGR of 3.9%, says MarketsandMarkets™

Chicago, Oct. 14, 2022 (GLOBE NEWSWIRE) — The global Turbine Oil Market is projected to reach USD 1.91 billion by 2030, at a CAGR of 3.9% from USD 1.40 billion in 2022, as per the recent study by MarketsandMarkets™. Turbine oils are being promoted by a number of manufacturers for use in a wide variety of equipment, including air compressors, vacuum pumps, and bearings. These elements are anticipated to have a substantial impact on the growth of the turbine oil market globally. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21842248 Browse in-depth TOC on “Turbine oil Market”254 – Market Data Tables 65 – Figures List of Key Players in Turbine oil Market: Royal Dutch Shell (Netherlands)ExxonMobil Corporation (US)BP plc (UK)TotalEnergies SE (US)Chevron Corporation (US)Idemitsu Kosan...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.